What to Know About the New Nasal Spray for Tough Depression
4 days ago · The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at …
Spravato Nasal Spray Can Now Be Used Alone for Treatment …
3 days ago · The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment …
Major depression: FDA approves esketamine nasal spray
5 days ago · The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in people who have not responded to at least …
FDA Approves Spravato Nasal Spray for Major Depressive Disorder
Jan 23, 2025 · The U.S. Food and Drug Administration (FDA) this week approved Johnson & Johnson’s Spravato (a ketamine-derived) nasal spray to treat major depressive disorder …
FDA Approves Spravato Nasal Spray for Treatment-Resistant …
Jan 22, 2025 · Spravato is the first and only approved monotherapy for adults with refractory major depressive disorder. Approval of Spravato, granted following FDA priority review, was …
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
Jan 24, 2025 · A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. ... as well as those with major …
FDA approves first-of-its-kind nasal spray for severe depression
Jan 22, 2025 · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
FDA Approves Spravato Nasal Spray for Treatment-Resistant
Jan 23, 2025 · The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate …
SPRAVATO® (esketamine): A Prescription Nasal Spray
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, when two or more oral antidepressants haven't worked. You are not alone. Millions of …
FDA approves new nasal spray medication for treatment-resistant ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried...